Characterization of a CD99-related 21 -kDa cellular protein(VAP21) incorporated into rabies virion

掺入狂犬病毒颗粒中的 CD99 相关 21 kDa 细胞蛋白 (VAP21) 的表征

基本信息

  • 批准号:
    12670281
  • 负责人:
  • 金额:
    $ 1.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

The VAP21, a CD99-related 21-kDa cellular transmembrane protein, was expressed in various types of organs of Syrian hamster as well as the hamster-derived cell lines (BHK-21 and HmLu-1). The protein displayed heterogeneous electrophoretic mobilities depending on the organs and cell lines probably due to different posttranslational modifications. The VAP21, however, was not expressed in other animal species we tested, including Chinese hamster, mouse, dog, monkey and human. We tried to express the VAP21 in VAP21-negative cell lines, such as CHO-K1 , HeLa, COS-7 and MDCK, using a tetracycline-regulated gene expression system. All of the trials, however, resulted in obtaining no permanently positive nor inducible cell lines : at the beginning of the cDNA transfection, cells were transiently positive for VAP21 expression, but the positive population decreased to undetectable levels within a few weeks, even though not a few G418-resistant clones were obtained. To the contrary, we could easily establish the VAP21-overexpressing cell lines from Syrian hamster cells, which were successfully maintained without any loss of VAP21 expression even under the induced culture conditions. Furthermore, although transfection of the VAP21 cDNA affected the recipient cells differently depending on the cell types, the VAP21 expression was somewhat of benefit to infection with the vesicular stomatitis virus as seen in the increased yield of progeny viruses. Interestingly, although VAP21 antigen was diffusely distributed as very fine dots over the entire cell surface of BHK-21 and HmLu-1 cells, alteration of the distribution pattern such as the development of bleb-shaped spots on the cell surface was observed both in BHK-21/VAP21 and HmLu-1/VAP21 cells. These results provide important implications for potential role of VAP21 in cellular function.
VAP 21是一种CD 99相关的21-kDa细胞跨膜蛋白,在叙利亚仓鼠的各种类型的器官以及仓鼠衍生的细胞系(BHK-21和HmLu-1)中表达。该蛋白质显示异质性电泳迁移率取决于器官和细胞系可能是由于不同的翻译后修饰。然而,VAP 21在我们测试的其他动物物种中不表达,包括中国仓鼠、小鼠、狗、猴和人。我们尝试使用四环素调控的基因表达系统在VAP 21阴性的细胞系中表达VAP 21,如CHO-K1、HeLa、COS-7和MDCK。然而,所有的试验都没有获得永久阳性或可诱导的细胞系:在cDNA转染开始时,细胞对VAP 21表达呈瞬时阳性,但阳性群体在几周内下降到不可检测的水平,即使获得了不少G418抗性克隆。相反,我们可以容易地从叙利亚仓鼠细胞中建立VAP 21过表达细胞系,即使在诱导培养条件下,该细胞系也成功地维持而没有VAP 21表达的任何损失。此外,尽管VAP 21 cDNA的转染对受体细胞的影响因细胞类型而异,但VAP 21的表达对水泡性口炎病毒的感染有些益处,如在子代病毒产量增加中所见。有趣的是,尽管VAP 21抗原作为非常细的点弥散分布在BHK-21和HmLu-1细胞的整个细胞表面上,但在BHK-21/VAP 21和HmLu-1/VAP 21细胞中均观察到分布模式的改变,例如在细胞表面上形成水泡状斑点。这些结果为VAP 21在细胞功能中的潜在作用提供了重要的启示。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sagara,J.: "Immunological studies of a 21 kDa cellular component efficiently incorporated into the rabies virion grown in a BHK-21 cellcultur"Microbiol.Immunol.. 41・12. 947-955 (1997)
Sagara, J.:“有效掺入 BHK-21 细胞培养物中生长的狂犬病毒粒子的 21 kDa 细胞成分的免疫学研究”Microbiol.Immunol.. 41・12 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakahara,K.: "Intracellular behavior of rabies virus matrix protein (M) is determined by the viral glycoprotein (G)"Microbiol.Immunol.. 43・3. 259-270 (1999)
Nakahara, K.:“狂犬病病毒基质蛋白 (M) 的细胞内行为由病毒糖蛋白 (G) 决定”《微生物学》,259-270 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Noguchi.T: "Effects of mutation in hepatitis C virus non-structural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells"Microbiol. Immunol.. 45・2. 829-840 (2001)
Noguchi.T:“丙型肝炎病毒非结构蛋白5A突变对哺乳动物细胞中PKR激酶活性抑制介导的干扰素抵抗的影响”Microbiol. 45・2(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sagara,J.: "The 21-kDa polypeptide (VAP21) in the rabies virion is a CD99-related host cell protein"Microbiol.Immunol.. 42・4. 289-297 (1998)
Sagara, J.:“狂犬病毒粒子中的 21-kDa 多肽 (VAP21) 是一种 CD99 相关宿主细胞蛋白” Microbiol.. 289-297 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Xiao, S.: "The rabies virion-associated 100-kDa polypeptide (VAP100) in a host-derived minor component of the viral envelope"Microbiol. Immunol.. 44. 657-668 (2000)
肖,S.:“病毒包膜的宿主衍生的次要成分中的狂犬病病毒粒子相关的 100-kDa 多肽(VAP100)”Microbiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOCHIKURA Tadafumi其他文献

TOCHIKURA Tadafumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Analysis of oxidative stress on off-target infection of activated T cells by oncolytic vesicular stomatitis virus
溶瘤性水泡性口炎病毒活化T细胞脱靶感染氧化应激分析
  • 批准号:
    467024
  • 财政年份:
    2021
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Studentship Programs
The Role of the Chemokine Receptor CXCR3 Axis in the Efficacy of Oncolytic Vesicular Stomatitis Virus Therapy in Combination with Natural Killer T Cell Activation Immunotherapy in Melanoma
趋化因子受体 CXCR3 轴在溶瘤性水泡性口炎病毒疗法联合自然杀伤 T 细胞激活免疫疗法治疗黑色素瘤的疗效中的作用
  • 批准号:
    449649
  • 财政年份:
    2020
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Studentship Programs
Characterization of novel viral sensitizers that enhance oncolytic herpes simplex-1 virus (HSV1) and vesicular stomatitis virus (VSV) infection in cancer cells through polo-like kinase-1(PLK1) inhibition
通过抑制 Polo 样激酶 1 (PLK1) 增强癌细胞中溶瘤单纯疱疹病毒 (HSV1) 和水疱性口炎病毒 (VSV) 感染的新型病毒敏化剂的特性
  • 批准号:
    428819
  • 财政年份:
    2019
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Studentship Programs
Removing hurdles to vesicular stomatitis virus vector production through rational design of a novel bioengineered cell line using CRISPR/Cas9 technology
利用 CRISPR/Cas9 技术合理设计新型生物工程细胞系,消除水泡性口炎病毒载体生产的障碍
  • 批准号:
    516424-2018
  • 财政年份:
    2019
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Postdoctoral Fellowships
Removing hurdles to vesicular stomatitis virus vector production through rational design of a novel bioengineered cell line using CRISPR/Cas9 technology
利用 CRISPR/Cas9 技术合理设计新型生物工程细胞系,消除水泡性口炎病毒载体生产的障碍
  • 批准号:
    516424-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Postdoctoral Fellowships
A Non-Canonical Translation Mechanism for Vesicular Stomatitis Virus
水泡性口炎病毒的非典型翻译机制
  • 批准号:
    9896764
  • 财政年份:
    2018
  • 资助金额:
    $ 1.47万
  • 项目类别:
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
静脉内水泡性口炎病毒治疗转移性子宫内膜癌的 I 期试验
  • 批准号:
    10000856
  • 财政年份:
    2017
  • 资助金额:
    $ 1.47万
  • 项目类别:
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
静脉内水泡性口炎病毒治疗转移性子宫内膜癌的 I 期试验
  • 批准号:
    9308083
  • 财政年份:
    2017
  • 资助金额:
    $ 1.47万
  • 项目类别:
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
水泡性口炎病毒 (VSV) 在恶性细胞中的复制
  • 批准号:
    9150544
  • 财政年份:
    2015
  • 资助金额:
    $ 1.47万
  • 项目类别:
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
水泡性口炎病毒 (VSV) 在恶性细胞中的复制
  • 批准号:
    9752480
  • 财政年份:
    2015
  • 资助金额:
    $ 1.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了